Resource Current research Find out about the research projects we are currently supporting as a charity. Print News, 25 Nov Clinical trials of COVID-19 vaccines All vaccines go through a robust clinical trial process and are only given to patients once they have met the strict safety, effectiveness and quality standards of the UK’s medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA). The UK has provided funding and responded quickly to fast-track the world’s most innovative vaccines for […] Article British Society for Rheumatology Biologics Register – RA The BSRBR-RA study tracks the progress of people with rheumatoid arthritis (RA) who have been prescribed biologic (including biosimilar) and other targeted therapies in the UK to monitor the long-term safety of these drugs. Article The National Early Inflammatory Arthritis Audit (NEIAA) The National Early Inflammatory Arthritis Audit (NEIAA) aims to improve the quality of care for people living with inflammatory arthritis, collecting information on all new patients over the age of 16 in specialist rheumatology departments in England and Wales.
News, 25 Nov Clinical trials of COVID-19 vaccines All vaccines go through a robust clinical trial process and are only given to patients once they have met the strict safety, effectiveness and quality standards of the UK’s medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA). The UK has provided funding and responded quickly to fast-track the world’s most innovative vaccines for […]
News, 25 Nov Clinical trials of COVID-19 vaccines All vaccines go through a robust clinical trial process and are only given to patients once they have met the strict safety, effectiveness and quality standards of the UK’s medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA). The UK has provided funding and responded quickly to fast-track the world’s most innovative vaccines for […]
Article British Society for Rheumatology Biologics Register – RA The BSRBR-RA study tracks the progress of people with rheumatoid arthritis (RA) who have been prescribed biologic (including biosimilar) and other targeted therapies in the UK to monitor the long-term safety of these drugs.
Article British Society for Rheumatology Biologics Register – RA The BSRBR-RA study tracks the progress of people with rheumatoid arthritis (RA) who have been prescribed biologic (including biosimilar) and other targeted therapies in the UK to monitor the long-term safety of these drugs.
Article The National Early Inflammatory Arthritis Audit (NEIAA) The National Early Inflammatory Arthritis Audit (NEIAA) aims to improve the quality of care for people living with inflammatory arthritis, collecting information on all new patients over the age of 16 in specialist rheumatology departments in England and Wales.
Article The National Early Inflammatory Arthritis Audit (NEIAA) The National Early Inflammatory Arthritis Audit (NEIAA) aims to improve the quality of care for people living with inflammatory arthritis, collecting information on all new patients over the age of 16 in specialist rheumatology departments in England and Wales.